肝癌内科治疗研究进展(6)
[20] 陳晓泓. 肝癌术后辅助性肝动脉化疗栓塞的价值及残癌危险因素分析[D]. 上海: 复旦大学, 2010.
[21] Zhang L, Hu P, Chen X, et al. Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis [J/OL]. PLoS One, 2014, 9(6): e100305[2016-10-22]. http://journals.plos.org/plosone/article/ file?id=10.1371/journal.pone.0100305&type=printable.
[22] Choi GH ......
您现在查看是摘要页,全文长 2697 字符。
[21] Zhang L, Hu P, Chen X, et al. Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis [J/OL]. PLoS One, 2014, 9(6): e100305[2016-10-22]. http://journals.plos.org/plosone/article/ file?id=10.1371/journal.pone.0100305&type=printable.
[22] Choi GH ......
您现在查看是摘要页,全文长 2697 字符。